SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 3.22 |
| Enterprise Value ($M) | -4.59 |
| Book Value ($M) | 6.61 |
| Book Value / Share | 4.97 |
| Price / Book | 0.49 |
| NCAV ($M) | 6.14 |
| NCAV / Share | 4.62 |
| Price / NCAV | 0.52 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.01 |
| Return on Assets (ROA) | -0.82 |
| Return on Equity (ROE) | -1.00 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.31 |
| Current Ratio | 3.31 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 8.87 |
| Assets | 9.34 |
| Liabilities | 2.73 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Armistice Capital, Llc | 9.99 | -74.19 | |
| 13G/A | Lind Global Fund II LP | 1.70 | -78.70 | |
| 13G/A | L1 Capital Global Opportunities Master Fund, Ltd. | 0.00 | -100.00 | |
| 13G/A | Intracoastal Capital, Llc | 1.90 | 37.72 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 4,688 | 21,315 | 21.99 | |
| 10,525 | 26,041 | 40.42 | |
| 8,380 | 31,142 | 26.91 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ORGO – Organogenesis Holdings Inc. | ORMP – Oramed Pharmaceuticals Inc. |
| OTLK – Outlook Therapeutics, Inc. | PCSA – Processa Pharmaceuticals, Inc. |
| PDSB – PDS Biotechnology Corporation |
Financial data and stock pages provided by
Fintel.io